BioSpace News Archive

Zambon announced that the Company will present findings examining how Chronic Lung Allograft Dysfunction is the leading cause of re-transplantation and associated with high healthcare costs during a rapid oral session at the American College of Chest Physicians® 2022 Annual Meeting being held October 16 – 19, 2022 in Nashville, TN.

Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India.

Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, continues to discuss the company’s RemeOs™ trauma screw market authorization with the U.S. Food and Drug Administration.